TMC
ECTE

Trellus Management Company’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Trellus Management Company’s Portfolio ECTE Stock Details ECTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-12,500
Closed -$31K – 137
2013
Q2 		$31K Buy
+12,500
New +$65.5K 0.04% 103

Other funds holding ECTE

PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NPC
National Planning Corporation El Segundo, California $726K AUM 14.28% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Trellus Management Company's ECTE Position: Q3 2013 in Review

Trellus Management Company sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2013, closing a stake of 12,500 shares — an estimated $31K sold.

Trellus Management Company first reported a position in ECTE in Q2 2013 and held it in 1 quarter. The position peaked at $31K in Q2 2013. 23 funds tracked by Wall St. Rank hold ECTE as of Q3 2013.

  • Trellus Management Company reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2013 after selling out during the quarter.
  • Trellus Management Company sold 12,500 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2013, an estimated $31K.
  • Trellus Management Company first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 1 quarter.
  • Trellus Management Company's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $31K in Q2 2013.
  • 23 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2013.

Based on Trellus Management Company's 13F filing for Q3 2013, filed 14 Nov 2013.